Specifically, in hepatocellular carcinoma, adenoid cystic carcinoma, pheochromocytoma, and various sarcomas, high levels of RBM39 are associated with patients’ poor overall survival; in contrast, the overexpression of RBM39 is linked to the prolonged overall survival of women affected by uterine carcinoma [127]. The gene discussed is RBM39; the disease is hepatocellular carcinoma.